Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima
- PMID: 9439479
- DOI: 10.1006/exmp.1997.2216
Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima
Abstract
The subfraction of low density lipoprotein (LDL) with low sialic acid content that caused accumulation of cholesterol esters in human aortic smooth muscle cells has been found in the blood of coronary atherosclerosis patients. It was demonstrated that this subfraction consists of LDL with small size, high electronegative charge, reduced lipid content, altered tertiary structure of apolipoprotein B, etc. LDL of this subfraction is naturally occurring multiple-modified LDL (nomLDL). In this study we compared the binding, uptake and proteolytic degradation of native LDL and nomLDL by smooth muscle cells cultured from human grossly normal intima, fatty streaks, and atherosclerotic plaques. Uptake of nomLDL by normal and atherosclerotic cells was 3.5- and 6-fold, respectively, higher than uptake of native LDL. Increased uptake of nomLDL was due to increased binding of this LDL by intimal smooth muscle cells. The enhanced binding is explained by the interaction of nomLDL with cellular receptors other than LDL-receptor. Modified LDL interacted with the scavenger receptor, asialoglycoprotein receptor, and also with cell surface proteoglycans. Rates of degradation of nomLDL were 1.5- and 5-fold lower than degradation of native LDL by normal and atherosclerotic cells, respectively. A low rate of nomLDL degradation was also demonstrated in homogenates of intimal cells. Activities of lysosomal proteinases of atherosclerotic cells were decreased compared with normal cells. Pepstatin A, a cathepsin D inhibitor, completely inhibited lipoprotein degradation, while serine, thiol, or metallo-proteinase inhibitors had partial effect. This fact reveals that cathepsin D is involved in initial stages of apoB degradation by intimal smooth muscle cells. Obtained data show that increased uptake and decreased lysosomal degradation of nomLDL may be the main cause of LDL accumulation in human aortic smooth muscle cells, leading to foam cell formation.
Similar articles
-
Naturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractions.Exp Mol Pathol. 1995 Jun;62(3):166-72. doi: 10.1006/exmp.1995.1018. Exp Mol Pathol. 1995. PMID: 8612720
-
Lysosomal enzymes are released from cultured human macrophages, hydrolyze LDL in vitro, and are present extracellularly in human atherosclerotic lesions.Arterioscler Thromb Vasc Biol. 2003 Aug 1;23(8):1430-6. doi: 10.1161/01.ATV.0000077207.49221.06. Epub 2003 May 15. Arterioscler Thromb Vasc Biol. 2003. PMID: 12750117
-
Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization.Lab Invest. 1992 Nov;67(5):665-75. Lab Invest. 1992. PMID: 1434544
-
Scavenger receptors and modified lipoproteins: fatal attractions?IUBMB Life. 2000 May;49(5):397-403. doi: 10.1080/152165400410245. IUBMB Life. 2000. PMID: 10902571 Review.
-
Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals.Med Electron Microsc. 2002 Dec;35(4):179-203. doi: 10.1007/s007950200023. Med Electron Microsc. 2002. PMID: 12658354 Review.
Cited by
-
Local Accumulation of Lymphocytes in the Intima of Human Aorta Is Associated with Giant Multinucleated Endothelial Cells: Possible Explanation for Mosaicism of Atherosclerosis.Int J Mol Sci. 2022 Jan 19;23(3):1059. doi: 10.3390/ijms23031059. Int J Mol Sci. 2022. PMID: 35162983 Free PMC article.
-
Approach to reduction of blood atherogenicity.Oxid Med Cell Longev. 2014;2014:738679. doi: 10.1155/2014/738679. Epub 2014 Jun 29. Oxid Med Cell Longev. 2014. PMID: 25101152 Free PMC article.
-
One-Year Conservative Care Using Sodium Bicarbonate Supplementation Is Associated with a Decrease in Electronegative LDL in Chronic Kidney Disease Patients: A Pilot Study.Cardiorenal Med. 2017 Oct;7(4):334-341. doi: 10.1159/000478733. Epub 2017 Aug 17. Cardiorenal Med. 2017. PMID: 29118772 Free PMC article.
-
Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases.Pharmacol Ther. 2011 Sep;131(3):338-50. doi: 10.1016/j.pharmthera.2011.04.010. Epub 2011 May 12. Pharmacol Ther. 2011. PMID: 21605595 Free PMC article. Review.
-
Sialic acid metabolism as a potential therapeutic target of atherosclerosis.Lipids Health Dis. 2019 Sep 14;18(1):173. doi: 10.1186/s12944-019-1113-5. Lipids Health Dis. 2019. PMID: 31521172 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous